These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 33866649

  • 21. International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories.
    St Ledger K, Feussner A, Kalina U, Horn C, Metzner HJ, Bensen-Kennedy D, Blackman N, Veldman A, Stowers A, Friedman KD.
    J Thromb Haemost; 2018 Mar; 16(3):555-564. PubMed ID: 29274194
    [Abstract] [Full Text] [Related]

  • 22. Multicentre pharmacokinetic evaluation of rFVIII-Fc (efmoroctocog alfa) in a real life and comparison with non-extended half-life FVIII concentrates.
    Pouplard C, Sattler L, Ryman A, Eschwege V, De Maistre E, Flaujac C, Szymezak J, Grand F, Repesse Y, Galinat H, Donnard M, Ternisien C, Iorio A, Chelle P, Jeanpierre E, ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO - GFHT).
    Haemophilia; 2020 Mar; 26(2):282-289. PubMed ID: 32107819
    [Abstract] [Full Text] [Related]

  • 23. Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories.
    Sommer JM, Moore N, McGuffie-Valentine B, Bardan S, Buyue Y, Kamphaus GD, Konkle BA, Pierce GF.
    Haemophilia; 2014 Mar; 20(2):294-300. PubMed ID: 24261554
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A field study evaluating the activity of N8-GP in spiked plasma samples at clinical haemostasis laboratories.
    Tiefenbacher S, Clausen WHO, Hansen M, Lützhøft R, Ezban M.
    Haemophilia; 2019 Sep; 25(5):893-901. PubMed ID: 31294905
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies.
    Kitchen S, Tiefenbacher S, Gosselin R.
    Semin Thromb Hemost; 2017 Apr; 43(3):331-337. PubMed ID: 28264199
    [Abstract] [Full Text] [Related]

  • 28. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
    Bassus S, Wegert W, Krause M, Escuriola-Ettinghausen C, Siegemund A, Petros S, Scholz T, Scharrer I, Kreuz W, Engelmann L, Kirchmaier CM.
    Platelets; 2006 Sep; 17(6):378-84. PubMed ID: 16973498
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clotting and chromogenic factor VIII assay variability in post-infusion and spiked samples containing full-length recombinant FVIII or recombinant factor VIII Fc fusion protein (rFVIIIFc).
    Kitchen S, Jennings I, Makris M, Kitchen DP, Woods TAL, Walker ID.
    Int J Lab Hematol; 2019 Apr; 41(2):176-183. PubMed ID: 30556650
    [Abstract] [Full Text] [Related]

  • 32. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R, Harmon S, Gannon C, Byrne M, O'Donnell JS, Jenkins PV.
    Haemophilia; 2010 Jul 01; 16(4):671-4. PubMed ID: 20148980
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Role of chromogenic assays in haemophilia A and B diagnosis.
    Bowyer AE, Duncan EM, Antovic JP.
    Haemophilia; 2018 Jul 01; 24(4):578-583. PubMed ID: 29808946
    [Abstract] [Full Text] [Related]

  • 38. Functional characteristics of N8, a new recombinant FVIII.
    Christiansen ML, Balling KW, Persson E, Hilden I, Bagger-Sørensen A, Sørensen BB, Viuff D, Segel S, Klausen NK, Ezban M, Lethagen S, Steenstrup TD, Kjalke M.
    Haemophilia; 2010 Nov 01; 16(6):878-87. PubMed ID: 20546031
    [Abstract] [Full Text] [Related]

  • 39. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
    Lewis SJ, Stephens E, Florou G, Macartney NJ, Hathaway LS, Knipping J, Collins PW.
    Br J Haematol; 2007 Sep 01; 138(6):775-82. PubMed ID: 17672884
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.